Rentokil Total Current Assets from 2010 to 2026
| RTO Stock | | | USD 30.92 -0.67 -2.12% |
Total Current Assets are reflecting a rebounding pattern with measured volatility. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.
View All Fundamentals Total Current Assets | First Reported 1985-12-31 | Previous Quarter 3.6 B | Current Value 2.9 B | Quarterly Volatility 861.7 M |
Black Monday | Oil Shock | Dot-com Bubble | Housing Crash | Credit Downgrade | Yuan Drop | Covid | Interest Hikes |
Compare Rentokil Initial against competitors using
Rentokil Initial Correlation. This supports competitive context.
Evaluating Rentokil Initial's Total Current Assets across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Rentokil Initial PLC's fundamental strength.
Latest Rentokil Initial's Total Current Assets Growth Pattern
Below is the plot of the Total Current Assets of Rentokil Initial PLC over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Rentokil Initial's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rentokil Initial's overall financial position and show how it may be relating to other accounts over time.
| Total Current Assets | 10 Years Trend | | |
Rentokil Total Current Assets Regression Statistics
| Arithmetic Mean | 1,516,867,921 |
| Geometric Mean | 1,101,278,479 |
| Coefficient Of Variation | 69.37 |
| Mean Deviation | 929,437,083 |
| Median | 926,100,000 |
| Standard Deviation | 1,052,232,925 |
| Sample Variance | 1107194.1T |
| Range | 3.2B |
| R-Value | 0.87 |
| Mean Square Error | 277899.5T |
| R-Squared | 0.76 |
| Slope | 182,215,485 |
| Total Sum of Squares | 17715106.1T |
Rentokil Total Current Assets History
| 2026 | 3 B | |
| 2025 | 2.9 B | |
| 2024 | 2.1 B | |
| 2023 | 2.7 B | |
| 2022 | 3.2 B | |
| 2021 | 1.3 B | |
| 2020 | 2.8 B | |
Rentokil Initial Valuation Metrics
Rentokil Initial is a large-cap equity in Environmental & Facilities Services, Commercial & Professional Services, Industrials categories. Cycle exposure impacts valuation range. This analysis reviews how Rentokil Initial integrates into a multi-asset portfolio across market cycles.
Methodology
Unless otherwise specified, financial data for Rentokil Initial PLC is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Rentokil (USA Stocks:RTO) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Valuation estimates and intrinsic-value models use inputs from public financial disclosures and may not represent market consensus.
Assumptions
The data underlying this report is sourced from public filings and market reference sources, including filings and releases published by
U.S. Securities and Exchange Commission (SEC) via
EDGAR. Some updates may be delayed based on publication cadence. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the
Model Inputs section. If you have questions about our data sources or methodology, please
contact Macroaxis Support.
Analyst Sources
Rentokil Initial PLC is covered by 4 analysts. 2 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Evercore ISI, Morgan Stanley, BMO Capital Markets, Oppenheimer & Co., Guggenheim Securities, among others. Updates may occur throughout the day.
Pair Trading with Rentokil Initial
Pair trading with Rentokil Initial can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
The information in the correlation table below can inform Rentokil Initial tax-loss harvesting decisions, showing which instruments historically move in lockstep with Rentokil Initial PLC and can serve as viable temporary replacements.
Negative correlation assets provide natural hedges against Rentokil Initial positions. When Rentokil Initial PLC's value declines, a negatively correlated instrument tends to rise, partially offsetting portfolio losses.
Pair evaluation and
Correlation analysis for Rentokil Initial provide hedging context. This approach is commonly reviewed within sectors and across broader groups.
Pair CorrelationCorrelation MatchingMore Resources for Rentokil Stock Analysis
A structured review of Rentokil Initial PLC often starts with core
financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for Rentokil Initial Plc Stock.
Highlighted below are reports that provide context for Rentokil Initial Plc Stock: Compare Rentokil Initial against competitors using
Rentokil Initial Correlation. This supports competitive context.
Analysis related to Rentokil Initial should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the
Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Quarterly Earnings Growth 0.883 | Dividend Share 0.124 | Earnings Share 0.57 | Revenue Per Share | Quarterly Revenue Growth -0.04 |
Investors evaluate Rentokil Initial PLC using market value and book value, each describing different facets of the business. Intrinsic value is an estimate of what Rentokil Initial's
fundamentals imply, and it may differ from market and book figures. External forces such as sentiment and macro conditions can shift prices away from fundamental signals. Analytical frameworks help compare those viewpoints.
Value and price for Rentokil Initial are related but not identical, and they can diverge across cycles. Evaluation typically reviews profitability, growth, balance sheet strength, industry position, and market signals. By contrast, market price reflects the level where buyers and sellers transact.